Tada Hiroomi 4
4 · Tyra Biosciences, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
Tada Hiroomi
Chief Medical Officer
Transactions
- Award
Common Stock
2022-09-15$7.66/sh+612$4,687→ 81,237 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.